News Wire

Almirall announced that both phase 3 studies of KX2-391 for actinic keratosis (AK), met the primary endpoint of complete clearance of AK lesions at Day 57 within the face or scalp treatment areas, each study achieving statistical significance (P < 0.0001) on this endpoint. Statistical significance (P…
The FDA approved Azedra (iobenguane I 131, Progenics Pharmaceuticals) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond…
The FDA has announced two new voluntary programs—the Quality Metrics Feedback Program and the Quality Metrics Site Visit Program—in response to stakeholder requests for continued information and feedback on quality metrics, and to provide methods for industry to engage and inform the FDA’s use…
Pfizer Inc. plans to increase research and development spending for the remainder of the year in an ambitious plan to accelerate the delivery of potential blockbuster treatments to market. The drugmaker raised projections for spending on research to $7.7 billion to $8.1 billion from $7.4 billion and…
CMS recently unveiled a plan that would affect about 40% of payments made to physicians by Medicare. The plan, which is open for public comment until September, combines the forms now needed for reimbursement for each doctor’s appointment into one form by charging a flat fee for many visits. …
Pfizer officials say they expect that perhaps 30 drugs in its pipeline will be approved through 2022. In addition, according to the Wall Street Journal (WSJ), the drugmaker says that it won’t be that affected by losses of exclusivity after 2020. Pfizer yesterday raised projections for…
One of the byproducts of the many hospital mergers that have occurred in recent years is that it makes it easier to transfer patients, the Star Tribune of Minnesota reports. That’s given rise to a term that’s fairly new but might become more prominent in health care reportage: diagnostic discordance. …
“We spend the majority of our money and resources addressing people once they’re sick,” Cigna’s CEO David Cordani told Business Insider (BI) in an interview last week. “We need to spend some more of our resources keeping people healthy in the first case, and identifying people who…
Under the ACA, CMS started to not just take the word of nursing homes regarding how well they are staffed, and instead started looking at payrolls to find the answer. That answer was pretty shocking, Kaiser Health News (KHN) reports. So shocking, in fact, that the government slapped its lowest rating…
Some heavy-hitting health care organizations think that the prior authorization process needs improvement, saying that it “can be burdensome for all involved—health care providers, health plans, and patients. Yet, there is wide variation in medical practice and adherence to evidence-based treatment.”…
Centene CEO Michael Niedorff told analysts on a call about second quarter earnings yesterday that “we’re not out there buying all the practices we can and all the clinics that we can.” That’s in response to Centene’s acquisition of Community Medical Group in Florida, which owns 15 health…
“I’ve fallen, and I can’t get up!” was first used in commercials for a company called LifeLine in the late 1980s and often as a punchline by comedians, but the deterioration associated with old age is no laughing matter for those going through it. That device depended on the patient contacting…
The birth control device Essure is taking its final bow. The United States was the last market in which Essure, manufactured by Bayer AG, had been sold. As the Wall Street Journal reports, the company decided to stop selling the product because of declining sales. “The U.S. is the only remaining market…
The small biotech company Alzheon hasn’t given up on its big push to get approval for tramiprosate, its beta-amyloid-targeting drug that it says can be used for patients genetically disposed to Alzheimer’s. FierceBiotech reports that the drug does better than placebo in stabilizing symptoms over…
Stanford University researchers have developed a device that can measure a person’s cortisol levels, according to a study in Science Advances. Cortisol is a biomarker that measures everything from emotional stress to immune function. The device functions by blocking the movement of charged ions through…

Pages